Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 23 Squamous Cell Carcinoma of Head and Neck 10 Melanoma 8 Lung Neoplasms 8 Neoplasms 7 Carcinoma 6 Skin Neoplasms 5 Neoplasm Metastasis 5 Carcinoma, Squamous Cell 5 Carcinoma, Basal Cell 5 Adenocarcinoma 5 Sarcoma 4 Mouth Neoplasms 4 Head and Neck Neoplasms 4 Colonic Neoplasms 4 Carcinoma, Renal Cell 4 Urinary Bladder Neoplasms 3 Recurrence 3 Oropharyngeal Neoplasms 3 Laryngeal Neoplasms 3 Carcinoma, Merkel Cell 3 Breast Neoplasms 3 Triple Negative Breast Neoplasms 2 Rectal Neoplasms 2 Pancreatic Neoplasms 2 Mesothelioma, Malignant 2 Hemangiosarcoma 2 Glioblastoma 2 Colorectal Neoplasms 2 Carcinoma, Hepatocellular 2

Interventions

liposomal doxorubicin 1 cemiplimab 1 Paclitaxel 1 Doxorubicin 1 Cyclophosphamide 1 Carboplatin 1 Albumin-Bound Paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Invasive Breast Cancer × cemiplimab × Clear all

NCT04243616 2025-09-05

CemiHALT

Medical College of Wisconsin

Phase 2 Active not recruiting

Invasive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡